| Literature DB >> 18350140 |
Alfonso J C Soler Bistué1, Daniel Birshan, Andrew P Tomaras, Manisha Dandekar, Tung Tran, Jason Newmark, Duyen Bui, Nisha Gupta, Keziah Hernandez, Renee Sarno, Angeles Zorreguieta, Luis A Actis, Marcelo E Tolmasky.
Abstract
BACKGROUND: Dissemination of antimicrobial resistance genes has become an important public health and biodefense threat. Plasmids are important contributors to the rapid acquisition of antibiotic resistance by pathogenic bacteria. PRINCIPALEntities:
Mesh:
Year: 2008 PMID: 18350140 PMCID: PMC2262945 DOI: 10.1371/journal.pone.0001800
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of ORFs found in pMET1.
| ORF | Position | G+C Content (%) | Protein (aa) | Best Blast-X Hit |
| Identity/similarity | Accession No. |
| 1 | 1,387–674 | 45 | 238 | Putative RepA protein [pCRY, | 2e-119 | 89/95 | NP_995415 |
| 2 | 2,198–1,839 | 42.6 | 118 | Putative transcriptional regulator [pCRY, | 2e-42 | 72/84 | NP_995417 |
| 3 | 2,451–2,906 | 48.7 | 151 | Transcription antiterminator [pCRY, | 2e-83 | 99/100 | NP_995418 |
| 4 | 3,534–4,244 | 57.3 | 236 | Type IV secretory pathway VirB1 component [pCRY, | 2e-132 | 99/99 | NP_995421 |
| 5 | 4,241–4,546 | 56.2 | 101 | Type IV secretory pathway VirB2 component [pCRY, | 9e-31 | 98/99 | NP_995422 |
| 6 | 4,559–7,297 | 52.8 | 912 | Pilx3-4/VirB3-4-like protein [ | 0.0 | 99/100 | AAP70302 |
| 7 | 7,316–8,026 | 49.2 | 236 | Type IV secretion system VirB5 component [pCRY, | 2e-98 | 84/90 | NP_995424 |
| 8 | 8,275–9,351 | 46.4 | 358 | Type IV secretory pathway VirB6 component [pCRY, | 1e-155 | 87/95 | NP_995426 |
| 9 | 9443–9580 | 57.4 | 45 | Hypotetical protein[pCRY, Yersinia pestis biovar Microtus str. 91001] | 9e-13 | 91/91 | AE017044.1 |
| 10 | 9,620–10,255 | 55.4 | 211 | Type IV secretion system VirB8 component [pCRY, | 4e-105 | 99/100 | NP_995427 |
| 11 | 10,252–11,160 | 56.9 | 302 | Type IV secretory pathway VirB9 component [pCRY, | 1e-170 | 99/100 | NP_995428 |
| 12 | 11,201–12,475 | 57.4 | 424 | Type IV secretory pathway VirB10 component [pCRY, | 0.0 | 96/97 | NP_995429 |
| 13 | 12,465–13,490 | 47.6 | 341 | Type IV secretory pathway VirB11 component [pCRY, | 0.0 | 99/100 | NP_995430 |
| 14 | 13,487–13,885 | 46.5 | 132 | Hypothetical protein YP_pCRY17 [pCRY, | 8e-73 | 98/100 | NP_995431 |
| 15 | 13,921–14,226 | 42.4 | 101 | Hypothetical protein YP_pCRY18 [pCRY, | 3e-52 | 99/99 | NP_995432 |
| 16 | 14,251–14,565 | 40 | 104 | Putative dopa decarboxylase protein remnant [ | 8e-41 | 96/97 | NP_995433 |
| 17 | 15,331–17,082 | 39.8 | 583 | Putative mobilization MobB protein [pCRY, | 0.0 | 99/99 | NP_995436 |
| 18 | 17,079 –17,846 | 48.7 | 255 | Putative mobilization protein MobC [pCRY, | 9e-144 | 99/100 | NP_995437 |
| 19 | 17,949–18,749 | 54.2 | 168 | Putative endonuclease [pK245, | 2e-54 | 62/76 | ABG56794 |
| 20 | 19,631–18,663 | 53.3 | 320 | Antirestriction protein ArdC [p29930, | 3e-152 | 86/92 | CAD58578. |
| 21 | 20,016–20,351 | 33.7 | 112 | Hypotetical protein AmetDRAFT_2972 [ | 2e-14 | 39/86 | ZP_00799958 |
| 22 | 20,348–20,680 | 31.1 | 111 | Hypothetical protein AmetDRAFT_2972 [ | 2e-05 | 43/60 | ZP_00799958 |
| 23 | 21,353–21,060 | 45.8 | 99 | Transcriptional regulador [ | 5e-34 | 72/86 | CAH19146 |
| 24 | 21,706–21,356 | 47.8 | 117 | Hypothetical protein [ | 1e-43 | 71/84 | CAH19145 |
| 25 | 22,100–22,717 | 45.8 | 205 | Plasmid partitioning protein ParF [p29930, | 3e-84 | 77/90 | CAD58556 |
| 26 | 22,772–23,011 | 47.3 | 79 | Partitioning protein ParG[p29930, | 9e-16 | 53/70 | CAD58557 |
| 27 | 24,886–23,630 | 46.8 | 417 | Hypothetical protein V12B01_09786 [ | 6e-134 | 59/74 | ZP_00991171 |
| 28 | 26,905–24,890 | 46.6 | 675 | Hypothetical protein V12B01_09791 [ | 0.0 | 73/84 | ZP_00991172 |
| 29 | 29,632–26,948 | 45.4 | 892 | Hypothetical protein V12B01_09796 [ | 0.0 | 67/80 | ZP_00991173 |
| 30 | 30,731–29,871 | 50.3 | 286 | Beta-lactamase precursor (TEM-1) | 2e-152 | 100/100 | NP_608310 |
| 31 | 32,270–31,431 | 50.3 | 279 | Beta-lactamase precursor | 1e-157 | 100/100 | NP_608309 |
| 32 | 33,103–32,315 | 53.6 | 262 | Adenylyltranferase [pJHCMW1, | 6e-145 | 99/100 | NP_608308 |
| 33 | 33,778–33,173 | 54.1 | 201 | Aminoglycoside 6′-N-acetyltransferase type Ib (AAC(6′)-Ib) | 1e-112 | 100/100 | NP_608307 |
| 34 | 35,317–34,478 | 50.3 | 279 | Beta-lactamase precursor | 1e-157 | 100/100 | NP_608309 |
| 35 | 36,150–35,362 | 53.6 | 262 | Adenylyltranferase [pJHCMW1, | 6e-145 | 99/100 | NP_608308 |
| 36 | 36,825–36,220 | 54.1 | 201 | Aminoglycoside 6′-N-acetyltransferase type Ib (AAC(6′)-Ib) | 1e-112 | 100/100 | NP_608307 |
| 37 | 37,565–37,008 | 54.3 | 185 | Resolvase [pJHCMW1, | 2e-95 | 99/100 | NP_608306 |
| 38 | 37,694–40,732 | 51.8 | 1015 | Transposase [pJHCMW1, | 0.0 | 100/100 | NP_608305 |
| 39 | 41,223–40,942 | 52.7 | 93 | Predicted transcriptional regulator [pCRY, | 7e-37 | 100/100 | NP_995443 |
| 40 | 41,157–41,516 | 52.1 | 120 | Hypothetical protein YP_pCRY30 [pCRY, | 1e-50 | 97/98 | NP_995444 |
| 41 | 41,545–41,204 | 53 | 107 | Hypothetical protein plu0442 [ | 2e-27 | 60/73 | NP_927795 |
Best hit selected according to genetic coherence rather than a minimal difference in score.
Done with tblastn
Including stop codon
Figure 1Genetic map of pMET1 and comparison to plasmid pCRY and chromosomal elements.
A. The genetic maps of pMET1 and pCRY are compared showing the homologous regions. The arrows indicate genes locations and orientation. Genes with different functions are shown with different colors and if the genes in the different structures shown are homologus they are represented with the same colors. Yellow: mobilization; green: replication and partition; red: antibiotic resistance; purple: virB/pilX-like; blue: transposition; grey: unknown. Since pCRY is smaller than pMET1, to represent it in circular form a dotted line was added to fill the gap. Solid line represents non-homologous DNA. B. Comparison of a pMET1 region with chromosomal HPIs or ICEs is shown using a linearized version of the plasmid. The HPIs shown are those from E. coli ECOR31 (HPIECOR31) [43], K. pneumoniae NTUH-K2044 (ICEKp1) [44], and Y. pestis KIM (HPIYp)[43]. The diagram shows the HP core regions, which are not at scale and are represented as in [43], and the RB-HPIs. The sequence described in this manuscript has been deposited in GenBank, accession number is EU383016.
Figure 2Genetic organization of transposons Tn3, Tn1331, Tn1332, and Tn1331.2.
The horizontal arrows indicate the location and direction of transcription of the genes. The genes are named only once for the sake of clarity. The light gray blocks show the 520-bp region direct repeats. Note that in Tn1332 one of the direct repeats is interrupted by an insertion of ISPpu17. The upper vertices of the dark gray triangles show points of insertion of DNA fragments that generate a new transposable element. The length of the base of each triangle defines the sizes of such DNA insertions. The curved dashed arrow to the right indicates that the transition Tn1331.2 to Tn1331 by deletion of one of the 3,047-bp occurred in the laboratory but it has not been confirmed to occur in nature. Stippled bar below Tn1331 indicates potential gene cassettes (GC).
Figure 3Replication region of pMET1.
A. The bar shows a genetic map of the pMET1 replication region and the GC content plot generated using a window size of 100 bp on top. Recombinant clones were obtained by inserting the indicated fragments into pCR2.1 or ligated to the pUC4K aph cassette. The ability to be maintained in E. coli C2110 (a polA mutant) of the recombinant plasmids made using pCR2.1 as vector is indicated to the right by a + or − sign. The ability to generate kanamycin resistant colonies in E. coli TOP10 of the indicated fragments when ligated to the aph cassette from pUC4K is also represented by a + or − sign. B. BLASTP comparison of the amino acid sequences of the putative RepA proteins from pMET1 and pCRY.
Figure 4Genetic structures located upstream of parF and parG.
A. The direct repeats within the pMET1 putative parH-like locus are shown in red. The diagram also shows the −35 and −10 sequences, as well as the inverted repeats (arrows). The inverted repeat within the putative parH locus is shown in blue. The beginning of the ParF amino acid sequence including the deviant Walker motif A and motif A' are shown. B. Logo plot [60], [61] of a multiple alignment of the direct repeats shown in red.
Comparison of amino acid sequences of VirB/PliX-like proteins
| pCRY AE017044.1 | ICEECOR31 AY233333.1 | ICEKp1 AB298504.1 | |
| VirB1 | 99/99 | 63/77 | 63/77 |
| VirB2 | 98/99 | 76/85 | 76/85 |
| VirB3-4-like | 97/98 | 99/100 | 98/99 |
| VirB5 | 84/90 | 83/98 | 84/89 |
| VirB6 | 87/95 | 87/92 | 95/96 |
| ORF9 | 97/97 | 100/100 | 97/100 |
| VirB8 | 99/100 | 98/100 | 99/99 |
| VirB9 | 98/100 | 99/99 | 98/99 |
| VirB10 | 96/97 | 95/96 | 95/95 |
| VirB11 | 99/100 | 99/100 | 97/99 |
Values indicate identity/similarity obtained by blastx comparison of each pMET1 ORF and the corresponding hypothetical protein from pCRY, ICEECOR31 and ICEKp1.